Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Sardinha, D. M. Silva, M. J. A. Bispo, S. K. S. da Silva, A. P. O. Lima, K. V. B. Ferreira, I. P. Lima, Lngc

Prevalence of COVID-19 vaccine hesitancy in Brazil: a systematic review and meta-analysis

  • Americas
  • All age groups
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tamuzi, J. L. Katoto, Pdmc Ndwandwe, D. E. Wiysonge, C. S. Nyasulu, P. S.

Prevalence of missed opportunities for vaccination (MOV) indicators among children aged 12-23 months in sub-Saharan African countries: An individual-level meta-analysis of DHS and MICS national household data surveys

  • Africa
  • Children
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.

Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.

Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis

  • All age groups
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ do Nascimento, G. R. da Silva Santos, A. C. Silva, N. N. T. Guilmaraes, N. S. Lima, A. A. Coura-Vital, W.

Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Xu, H. Tiffany, A. Luquero, F. J. Kanungo, S. Bwire, G. Qadri, F. Garone, D. Ivers, L. C. Lee, E. C. Malembaka, E. B. Mendiboure, V. Bouhenia, M. Breakwell, L. Azman, A. S.

Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis

  • All age groups
  • Cholera
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mariscal-Lopez, E. Agredano-Sanchez, M. Lopez-Gigosos, R. M. Mariscal, A. Farinas-Guerrero, F. Gutierrez-Bedmar, M. Guts-Chornoknyzha, M.

Protective effect of adult vaccination on the development of dementias: A systematic review

  • Adults
  • Older adults
  • Influenza
  • Tetanus
  • Diphtheria
  • Pertussis
  • Herpes zoster
  • Pneumococcal disease
  • Tuberculosis
  • Rabies
  • Hepatitis A
  • Typhoid
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Patel, V. Korsun, M. Cervia, J.

Protective effects of booster dose of SARS-COV-2 vaccination against post-acute COVID-19 syndrome: A systematic review

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ekhator, E. Essien, V. G. Afolabi, O. E. Okundaye, M. I. Adewonbi, T.

Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review

  • Africa
  • Parents/caregivers
  • Malaria
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Katsandres, S. C. Scheele, S. K. Kiener, T. Bloudek, L.

Public Health Impact of the MVA-BN Vaccine During the 2022 Mpox Outbreak: A Systematic Review

  • All age groups
  • Mpox
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
Loading...